Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
Journal: Hepatology (Baltimore, Md.)
Published: October 26, 2017
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
Journal: European journal of radiology
Published: March 28, 2017
Transarterial approaches to primary and secondary hepatic malignancies.
Journal: Nature reviews. Clinical oncology
Published: May 20, 2015
Locoregional therapy of hepatocellular carcinoma.
Journal: Clinics in liver disease
Published: April 30, 2015
Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
Journal: Transplantation
Published: April 24, 2015
Defensive medicine in neurosurgery: does state-level liability risk matter?
Journal: Neurosurgery
Published: September 26, 2014
Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis.
Journal: Journal of vascular and interventional radiology : JVIR
Published: June 23, 2014
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 02, 2014
Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: January 09, 2014
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy.
Journal: Hepatology (Baltimore, Md.)
Published: November 12, 2013
Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.
Journal: International journal of radiation oncology, biology, physics
Published: October 10, 2013
Last Updated: 09/26/2026